| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |